131 related articles for article (PubMed ID: 8535408)
1. Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET).
Taniuchi H; Fujibayashi Y; Okazawa H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1995 Aug; 18(8):1126-9. PubMed ID: 8535408
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (cu-PTSM).
Shibuya K; Fujibayashi Y; Yoshimi E; Sasai K; Hiraoka M; Welch MJ
Ann Nucl Med; 1999 Oct; 13(5):287-92. PubMed ID: 10582796
[TBL] [Abstract][Full Text] [Related]
4. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.
Fujibayashi Y; Taniuchi H; Wada K; Yonekura Y; Konishi J; Yokoyama A
Ann Nucl Med; 1995 Feb; 9(1):1-5. PubMed ID: 7779524
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
6. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
7. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
8. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
9. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
[TBL] [Abstract][Full Text] [Related]
10. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi Y; Taniuchi H; Yonekura Y; Ohtani H; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1155-60. PubMed ID: 9225812
[TBL] [Abstract][Full Text] [Related]
11. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
Okazawa H; Yonekura Y; Fujibayashi Y; Mukai T; Nishizawa S; Magata Y; Ishizu K; Tamaki N; Konishi J
J Nucl Med; 1996 Jul; 37(7):1089-93. PubMed ID: 8965175
[TBL] [Abstract][Full Text] [Related]
12. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
13. Copper-trafficking efficacy of copper-pyruvaldehyde bis(N4- methylthiosemicarbazone) on the macular mouse, an animal model of Menkes disease.
Munakata M; Kodama H; Fujisawa C; Hiroki T; Kimura K; Watanabe M; Nishikawa M; Tsuchiya S
Pediatr Res; 2012 Sep; 72(3):270-6. PubMed ID: 22728746
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.
Adonai N; Adonai N; Nguyen KN; Walsh J; Iyer M; Toyokuni T; Phelps ME; McCarthy T; McCarthy DW; Gambhir SS
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3030-5. PubMed ID: 11867752
[TBL] [Abstract][Full Text] [Related]
15. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
[TBL] [Abstract][Full Text] [Related]
16. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
Circulation; 1990 Sep; 82(3):990-7. PubMed ID: 2394015
[TBL] [Abstract][Full Text] [Related]
17. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
18. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives.
John EK; Green MA
J Med Chem; 1990 Jun; 33(6):1764-70. PubMed ID: 2342070
[TBL] [Abstract][Full Text] [Related]
20. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia.
Taniuchi H; Fujibayashi Y; Yonekura Y; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1130-4. PubMed ID: 9225805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
